Product Categories

Proteasome

  • Compare Proteasome Inhibitors

Proteasome Inhibitors (13)

water-soluble

Cat.No. Product Name Information Product Citations Customer Reviews
S1013 Bortezomib (Velcade) Bortezomib is a potent 20S proteasome inhibitor with Ki of 0.6 nM.
S2619 MG-132 MG-132 (ZLLLal) is potent inhibitor of proteasome with IC50 of 100 nM.
S2853 Carfilzomib (PR-171) Carfilzomib (PR-171) is a proteasome inhibitor with IC50 less than 5 nM.
S2181 MLN9708 MLN9708 is a selective inhibitor of chymotrypsin-like proteolytic (β5) site of the 20S proteasome with IC50 and Ki of 3.4 nM and 0.93 nM.
S2180 MLN2238 MLN2238 inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with IC50 and Ki of 3.4 nM and 0.93 nM, respectively.
S7038 Epoxomicin (BU-4061T)
S7021 GS-9256 GS-9256 is a novel phosphinic acid derived inhibitor of the HCV NS3/4A protease with IC50 of 4 nM.
S7049 Oprozomib (ONX 0912) Oprozomib (ONX 0912) selectively inhibits CT-L activity of 20S proteasome β5/LMP7 with IC50 of 36 nM/82 nM.
S1183 Danoprevir Danoprevir is a peptidomimetic inhibitor of the NS3/4A protease of hepatitis C virus (HCV) with IC50 of 0.2-3.5 nM.
S1157 Delanzomib (CEP-18770) CEP-18770 is a potent chymotrypsin-like proteasome inhibitor with IC50 of 3.8 nM.
Cat.No. Product Name Information Product Citations Customer Reviews
S1386 Nafamostat mesylate Nafamostat is an anticoagulant.
S2101 Gabexate mesylate Gabexate is a serine protease inhibitor with IC50 of 0.19 μM which is used therapeutically in the treatment of pancreatitis and disseminated intravascular coagulation.
S3017 Aspirin (Acetylsalicylic acid) Aspirin is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication.
Page:
  • 1
  • 2
All Proteasome Inhibitors
Tags: Proteasome inhibition | ubiquitin-Proteasome system | ubiquitin-Proteasome pathway | Proteasome activity | Proteasome function | ubiquitin-Proteasome degradation | Proteasome assay | Proteasome structure | Proteasome purification | Proteasome inhibitors in cancer therapy | Proteasome cleavage | 20s Proteasome activity | 26s Proteasome structure | Proteasome inhibition assay | Proteasome inhibitor drugs | Proteasome inhibitor review